C83.7A
BillableBurkitt lymphoma, in remission
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is C83.7A an HCC code?
Yes. C83.7A maps to Lung and Other Severe Cancers under the CMS-HCC V28 risk adjustment model (and Lymphoma and Other Cancers under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for C83.7A
For C83.7Ato count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C83.7A during that encounter — not just copy-forwarded from a problem list.
What This Code Means
C83.7A is the ICD-10-CM diagnosis code for burkitt lymphoma, in remission. Burkitt lymphoma that is in remission, meaning the cancer is no longer detectable or has responded well to treatment. C83.7A sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of lymphoid, hematopoietic and related tissue (c81-c96).
Under the CMS-HCC V28 risk adjustment model, C83.7A maps to Lung and Other Severe Cancers (HCC 20) with a community, non-dual, aged base RAF weight of 0.000. Under the older CMS-HCC V24 model, C83.7A maps to Lymphoma and Other Cancers (HCC 10) with a community, non-dual, aged base RAF weight of 0.675. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Use this code only when documentation explicitly states the patient is in remission or complete response. Because C83.7A maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C83.7A sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Use this code only when documentation explicitly states the patient is in remission or complete response
- •This code can be used regardless of the anatomical site originally involved
Clinical Significance
Burkitt lymphoma in remission indicates the patient has completed treatment and the disease is no longer actively detectable, though ongoing surveillance is required due to risk of relapse. This code is important for risk adjustment because it captures the ongoing complexity of managing a patient with a history of this highly aggressive malignancy. Even in remission, patients require regular imaging, laboratory monitoring, and assessment for late treatment effects.
Documentation Requirements
- ✓Explicit provider documentation stating 'remission' — complete or partial remission must be stated
- ✓Supporting evidence such as negative PET/CT, normal labs, or pathology confirmation of no residual disease
- ✓History of confirmed Burkitt lymphoma diagnosis
- ✓Current surveillance or follow-up plan documented
- ✓Date of last treatment and duration of remission if available
Commonly Confused Codes
- •C83.70-C83.79 — Active Burkitt lymphoma by site: Use these codes only when disease is active, not in remission
- •Z85.79 — Personal history of other lymphoid, hematopoietic and related tissue malignancies: Use only when the lymphoma is considered cured and no longer being monitored as active disease; C83.7A is appropriate while still under active oncology surveillance
- •C83.8A — Other non-follicular lymphoma, in remission: Different lymphoma subtype; verify pathology confirms Burkitt specifically